After puromycin selection, single stable cells were isolated and subjected to MTCH2 KO screening, which led to the establishment of single-cell-derived NSCLC-1 MTCH2 KO selections: “koMTCH2-Slc1” and “koMTCH2-Slc2”. This evidence concerns the gene MTCH2 and non-small cell lung carcinoma.